ReviewAging and disease2021

Comparative Analysis of Aducanumab, Zagotenemab and Pioglitazone as Targeted Treatment Strategies for Alzheimer's Disease.

Morteza Abyadeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.